XBAS:F:F-Xtrackers MSCI Singapore UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 1.6074

Change

+0.04 (+2.85)%

Market Cap

USD 0.07B

Volume

70.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.28 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.46 (+0.90%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+3.08 (+0.52%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.51 (+0.91%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUAA:F Vanguard S&P 500 UCITS Acc

+2.06 (+1.97%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+6.73 (+6.72%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

+0.06 (+0.74%)

USD 40.89B
0ZC:F Zscaler Inc

+6.16 (+3.41%)

USD 37.92B

ETFs Containing XBAS:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.42% 85% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.42% 85% B 76% C+
Trailing 12 Months  
Capital Gain 28.69% 77% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.69% 77% C+ 70% C-
Trailing 5 Years  
Capital Gain 16.72% 47% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.72% 47% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 4.66% 54% F 56% F
Dividend Return 4.66% 52% F 49% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.54% 53% F 83% B
Risk Adjusted Return 37.15% 51% F 60% D-
Market Capitalization 0.07B 25% F 27% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.